First Lady Jill Biden, PhD, met with top UCSF cancer experts during a visit last week to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot. The visit was timed to mark Breast Cancer Awareness Month in October.
|
|
|
|
The Prostate Cancer Action Network of SF CAN recently hosted a Blue-Ribbon Car Show to raise awareness about the risk of prostate cancer in the African American community. |
|
|
|
UCSF's Luke Gilbert, PhD, is among the investigators awarded Phase 1 funding of the newly launched Molecular Phenotypes of Null Alleles in Cells (MorPhiC) program. |
|
AACR Cancer Progress Report 2022 |
|
|
|
The report highlights advances against cancer over the past year made possible by federally-funded medical research.
|
|
Daniel Kwon, MD received a grant from the DOD US Army Medical Research Acquisition Activity for a project, "Improving informed decision-making for precision oncology in Veterans with advanced prostate cancer."
S. John Liu, MD, PhD, Luke Gilbert, PhD, David Raleigh MD, PhD, and William A. Weiss, MD, PhD received a 2022 Catalyst Award for a project, "High-resolution Discovery of Novel Therapeutics for Glioblastoma Using in vivo CRISPR Perturb-seq."
|
|
Rugo HS, Bardia A, Marmé F, Cortes J, Schmid P, Loirat D, Trédan O, Ciruelos E, Dalenc F, Pardo PG, Jhaveri KL, Delaney R, Fu O, Lin L, Verret W, Tolaney SM. Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. J Clin Oncol. 2022 Oct 10;40(29):3365-3376.
Keenan BP, McCarthyEE, Ilano A, Yang H, Zhang L, Allaire K, Fan Z, Li T, Lee DS, Sun Y, Cheung A, Luong D, Chang H, Chen B, Marquez J, Sheldon B, Kelley RK, Ye CJ, Fong L. Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce Tcell paralysis. Cell Rep. 2022 Sep 20;40(12):111384.
Bennett NK, Nakaoka HJ, Laurent D, Okimoto RA, Sei Y, Horvai AE, Bivona TG, Ten Hoeve J, Graeber TG, Nakamura K, Nakamura JL. Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function. PLoS Biol. 2022 Sep 22;20(9):e3001753. |
|
Oct 19, 2022 | 12:00 - 1:00 pm
In this quarterly lecture hosted by the Office of Community Engagement, Dr. Leticia Márquez-Magaña will discuss the health effects of structural racism and culturally relevant coping mechanisms for racism stress.
|
|
|
UCSF has several opportunities for med students to do research. Check out our new Medical Student Research page to see the opportunities and ways to connect with them (including help with the LabSpot database). |
|
|
Nov 18, 2022 | 10:30 am - 12:00 pm
Representatives from ASCO, AACR, American Cancer Society, and the Damon Runyon Cancer Research Foundation will present funding opportunities along with tips for applying. Presentations will be followed by a Q&A period with UCSF faculty who have served on the review committees for these awards. Learn more and register.
2023 cohort applications due Dec 1, 2022
|
|
Sebastian Waszak, PhD (UCSF) will present, "Reconstructing the past and predicting the future: novel methods to map the genetic and cellular origin of brain tumors."
Featuring presentations by Drs. Eric Small, Peter Carroll, Matt Cooperberg, Felix Feng, June Chan, Mack Roach, Rahul Aggarwal, Thomas Hope, and many others.
This mini-symposium will focus on preclinical imaging and therapeutic capabilities and access to high-end, clinically translatable preclinical imaging technology.
The goal of a sample size justification is to determine how much data will provide valuable information for a study. This workshop will help you understand the theory and approaches of sample size justification with explicit examples.
NOVA 12 is a 12-mile walk around San Francisco representing the 12% of women who develop breast cancer.
|
|
|
|
|
|
|
